Federal Advocacy / Issues / Legislation

Join in the effort to promote the Federal Patient Access to Pharmacist's Services.  Take action Community pharmacy advocacy and issues at the national level with NCPA.  Read more  Health-system pharmacy advocacy and issues at the federal level with  Find out more.

 Click here for contact information to Montana's Congressional Delegation

Email, phone, fax and mailing address for US Representative Greg Gianforte, Senator Steve Daines and Senator Jon Tester.

NCPA’s Advocacy Report provides a weekly detailed summary of recent and breaking legislative, regulatory and state developments impacting independent community pharmacy, and NCPA efforts to effect policies to benefit its membership and the industry. The weekly report is distributed to NCPA leadership, key committees, allied organizations / stakeholders and major contributors to the NCPA LDF and PAC. 

Week Ending April 20, 2018
NCPA Introduces MedPAC Nominee to Key Hill Staff:  This week NCPA government affairs staff accompanied NCPA’s Medicare Payment Advisory Commission (MedPAC) nominee Troy Trygstad to meetings with staff from key Congressional committees that have jurisdiction over Medicare.  Read the full report.  Attachments referenced in the report:  HR 4275 Letter of Support;   NIOSH Comments

Week Ending April 13, 2018
Community Pharmacists Charge the Hill:  This week, nearly 300 community pharmacists from 37 states participated in NCPA’s 50th annual Congressional Pharmacy Summit. They charged Capitol Hill to advocate for NCPA’s three priority issues: an end to retroactive pharmacy DIR fees, transparency in generic reimbursement rates in federal programs, and to open Medicare preferred pharmacy networks to all pharmacies willing to accept contractual terms and conditions.  Read the full report.  Attachments that are referenced in the report.  Opioid HearingOpioid ResponseEPCS LetterAIDD Letter

Week Ending April 6, 2018
Congressional Committees Continue Work on Opioids: Next week, both chambers of Congress will hold hearings on the opioid crisis.  Read the full report.

Special Report of April 4, 2018
On April 2, 2018 The Centers for Medicare & Medicaid Services released their final Part D Rule and final Call Letter for 2019 Medicare Part D and Medicare Advantage plans.   Read the full report.

Week Ending March 30, 2018
Provider Status Legislation Offered as Part of Solution to Opioid Crisis
:  Progress continues to be made on provider status legislation, the “Pharmacy and Medically Underserved Areas Enhancement Act.”  Read the full report.  Attachments referenced in the report:  Congressional Summit AgendaGrassley Letter

Week Ending March 23, 2018
NCPA Responds to Senate Drug Pricing Transparency Request:  On Friday, NCPA responded (see attached) to a request from six Senators, led by Sen. Bill Cassidy (R-La.) and including Sen. Michael Bennet (D-Colo.), Sen. Charles Grassley (R-Iowa), Sen. Tom Carper (D-Del.),Sen. Todd Young (R-Ind.) and Sen. Claire McCaskill (D-Mo.), for comments regarding the ongoing effort to improve health care price and information transparency.  Read the full report.  Attachments to this report:  NCPA Senate Drug Pricing Transparency Request; 2018 Congressional Summit Agenda;  White House Fact Sheet Opioid.

Week Ending March 16, 2018
NCPA Offers Opioid Recommendations to Key Committee:  In a letter to the chairman and ranking member of the House Ways and Means Subcommittee on Health this week, NCPA offered several suggestions on how to combat the ongoing opioid crisis.  Read the full report.

Community Pharmacist Advises Congress on Opioid Epidemic: At a Feb. 28 hearing of the House Energy & Commerce Subcommittee on Health NCPA member Richard Logan, Jr., Pharm.D. who owns two pharmacies in Missouri and is a recently retired drug diversion investigator with the Mississippi County, MO Sheriff’s Department, testified on behalf of NCPA.  Read the full report.